Apr 3, 2020| JD Health
Wall Street Journal Highlights JD Health’s Online Consultation
by Tracy Yang
An article entitled “Telemedicine, once a hard sell, can’t keep up with demand” was published by the Wall Street Journal yesterday. The article discussed the huge demand generated from COVID-19 for telemedicine and how various companies in the world, like Teladoc, Doctor on Demand and others tried their best to add doctors and bandwidth to meet the demand from users.
JD Health’s initiative to launch the online consulting services to connect Chinese doctors with 60 million overseas Chinese was highlighted in the article. It also mentioned that the doctors on the platform have first-hand experience in combating the coronavirus.
In JD Health’s eyes, the pandemic has sped up the adoption of telemedicine by Chinese consumers by five years. The article also mentioned that the telemedicine industry faces challenges such as government regulation, insurance and reimbursements and patients’ trust.
Aug 26, 2021| JD Health
JD Health H1 FY21 Earnings: Users Growth, Cold Chain Medicine Delivery and Digital Transformation
by Vivian Yang and Hui Zhang
JD Health reported its H1 FY21 earnings results on August 25. Highlights include:
- Revenue growth of 55.4% year-on-year to RMB 13.64 billion
- Annual active users on the platform reached 109 million, an increase of more than 18.8 million new users for the 12 months ended June 30, 2021
- Retail pharmacy businesses have covered 400,000 SKUs
- Over 130,000 doctors are practicing either full-time or part-time on the platform, with average daily online consultations exceeding 160,000
JD Health is positioned to create a technology-driven platform that centers on the supply chain of pharmaceutical and healthcare products and is strengthened by healthcare services, encompassing a user’s full life span for all healthcare needs. In the first half of the year, JD Health has expanded its technological capabilities to support the digital transformation of real-economy enterprises in China, in particular SMEs and organizations from the grassroots and rural areas.
“We are constantly strengthening our capabilities on ‘retail pharmacy + healthcare services,’ and will continue to make progress on opening them up to society,” said Lijun Xin, CEO of JD Health. “On the one hand, we aim at supporting the digital transformation process of enterprises across the industrial value chain. On the other hand, we have increased investment on social value creation by providing digital technologies to support health services development in grassroots level and rural areas, promoting inclusive healthcare services to every user and making more contributions to the high-quality growth of China’s real economy.”
With the resurgence of COVID cases in China since early 2021, JD Health has been upgrading its online platform and offline service network, with experiences accrued last year, to provide bookings and home services for the public to conduct nucleic acid tests and vaccinations.
When Henan province was inundated by severe floods in mid-July this year, the company responded swiftly in the relief work including launching 24/7 free online medical consultation services, donating disinfection and anti-pandemic materials, dispatching medical rescue teams on site, and providing supportive measures for local partners and SMEs.
In this March, JD Health established its Rare Diseases Care Center to build a one-stop solution platform for patients with rare diseases, helping them to tackle difficulties in accessing medical treatment, medicine, insurance and charity support.
Health Products Distribution
JD Health’s self-operated business grew by 52.9% reaching RMB 11.8 billion during the reporting period. It is currently operating 17 medicine warehouses and over 350 non-medicine warehouses. Leveraging JD Logistics nationwide infrastructure, it has established cold-chain delivery capabilities in about 100 cities across China. To further expand people’s access to new special medicines, JD Health also opened a number of next-to-hospital and DTP drug stores offline.
During the reporting period, JD Health continued to deepen cooperation with leading pharmaceutical companies including UBC China, Sanofi China, Novartis, Guilong Pharmaceutical and more, with the goal to improve medicine circulation in China through a highly-efficient, digitalized and intelligent medicine supply chain.
Meanwhile, the company is leveraging the Customer-to-Manufacturer (C2M) model to help more producers create customized products for targeted users, further promoting the upgrade of consumption and the industrial value chain. A number of customized products under JD Health’s C2M model have been introduced to the market and have gained popularity in H1 this year, including Chinese-New-Year themed masks, masks with essence oil, scented disinfectant gel, antibacterial hand cream and more.
JD Health has also stepped up efforts on its omni-channel deployment and pharmacy alliance model. In the first half of the year, JD’s fast drug delivery services have covered over 300cities across the country, providing 24/7 service for customers. Meanwhile, it extended smart supply chain capabilities to SMEs to improve cost and operating efficiency, supporting over 500 drug stores under the JD Pharmacy Alliance across the country.
JD Health continued to improve its online consultation services by introducing more specialized medical centers online. As of June 30, the number of specialized medical centers rose to 24, with the number of both internal and external physicians and specialists exceeding 130,000. The average daily online consultation volume in the first half of the year continued to skyrocket during the report time, surpassing 160,000.
In 2020, JD Health launched the “family doctor” telemedicine service program to provide timely, consistent and comprehensive primary healthcare support for Chinese families. During the report period, the number of active users of JD’s “family doctor” services accounted for 87% of the total number of service users. The average monthly user growth rate so far reached 220%.
JD Health also continued to integrate online and offline services by providing users with services such as physical examination, medical cosmetology, stomatology, nucleic acid testing, vaccines and so on.
JD Health has been constantly offering intelligent solutions for offline institutions such as local governments and offline hospitals among others to contribute in optimizing the reasonable allocation of medical services and resources. For example, JD Health launched its first Internet hospital for Traditional Chinese Medicine (TCM) in cooperation with the First Affiliated Hospital of Henan University of Chinese Medicine.
Leveraging JD’s big data, AI, 5G among other technologies, JD Health is also helping to promote the construction of “Health City” projects in several cities including Beihai in Guangxi, Taicang in Jiangsu and Hebi in Henan. Meanwhile, JD Health also provides a one-stop omni-channel digital intelligence solution for offline retail pharmacies, helping to connect industry to commerce, commerce to terminal pharmacies, and pharmacies to users, and further promoting the transformation and upgrading of traditional offline retail pharmacies.
Aug 20, 2021| JD Health
JD Health “Family Doctor” Anniversary: Monthly User Growth Rate Doubles
by Hui Zhang
JD Health announced its achievements at a virtual event in celebration of the first anniversary of its “family doctor” service on Aug 18, showcasing two impressive numbers, with one being active users accounting for 87% of the total number of the service users, and the other being the 220% average monthly user growth rate.
On the occasion of the celebration, JD Health also inaugurated a public welfare program to help the Alzheimer’s patients in partnership with the China Aging Development Foundation, a national charity organization. Through the program, JD Health provides early detection services to 10,000 users over 60 years old. Meanwhile, it will also offer financial assistance to underprivileged patients, and help patients plan rehabilitation and disease management.
“Since the establishment of the family doctor service, we aim to become the effective ‘physicians,’ ‘communicators,’ ‘health managers,’ ‘coordinators,’ and ‘health financiers’ to help users in health management,” said Lijun Xin, CEO of JD Health.
Lijun Xin, CEO of JD Health, on the stage
JD Health has continuously optimized its user experience through increasing service points of entry for consumers. So far, in addition to online consultation through JD’s App, JD Health also introduced tailor-made telehealth services targeted at senior users who can use voice commands to access the service through an AI-based speaker. Meanwhile, users who are not familiar with mobile or internet usage can also dial in through s hotline service 950619. Recently, a new function to support multiple people online to seek consultation at the same time has also successfully launched within JD’s app. For example, children and their parents can call in to seek for consultation at the same time to bring peace of mind for both groups.
The “family doctor” service now covers different categories of patients, such as chronic disease patients and sub healthy people. The service not only provides professional medical assistance, but also helps them to create a health management plan to improve their health conditions.
The “family doctor” services program launched this August is tailor-made to provide timely, consistent and comprehensive primary healthcare support for families. It targets serving over 50 million families in the next five years.
Stay up to date on the latest news from JD.com
Enter your email address to subscribe to this blog and receive notifications of new posts by email.